Meningiomas may not live only 10 years. Most benign meningiomas can extend the survival of patients with timely and effective treatment, and the survival period can exceed 10 years. A small number of meningiomas located in more dangerous locations such as the base of the skull or the front of the brainstem, or with high malignancy and serious complications, may have a poor prognosis and may have a survival time of less than 10 years without timely treatment. Benign meningiomas can usually be removed surgically, and drugs such as mannitol are often used to control intracranial pressure before surgery. After surgical removal of the meningioma, the meningioma also needs to be controlled with medications or radiation therapy, commonly used drugs such as mifepristone and pregnenolone. In addition, patients with seizures need to be controlled by drugs such as sodium phenobarbital, which can be administered orally. Benign meningiomas also have a certain chance of recurrence after resection and require regular follow-up. After standard treatment, patients generally have a survival period of more than 10 years. A small number of meningiomas in dangerous locations can be treated with radiotherapy and surgery, and the choice of treatment modality is recommended to follow medical advice. Malignant meningiomas can be treated with radiotherapy, chemotherapy and targeted therapy in addition to surgery, and if surgery is timely and complete, survival may exceed 10 years. Therefore, it is recommended that active treatment after diagnosis of meningioma can effectively improve the prognosis and prolong the survival period.